Alzamend Neuro, Inc.ALZNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank22
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P22
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -12.97% |
| 2024 | -53.09% |
| 2023 | 4.31% |
| 2022 | 95.50% |
| 2021 | 8.52% |
| 2020 | 156.30% |
| 2019 | 127.64% |
| 2018 | -54.83% |
| 2017 | 1732.82% |
| 2016 | 0.00% |